Your session is about to expire
← Back to Search
Screening (genetic testing) for Colon Cancer
N/A
Waitlist Available
Led By John H Strickler
Research Sponsored by Academic and Community Cancer Research United
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3.5 years
Awards & highlights
Summary
This trial screens patients with colon or rectal cancer that has spread to other places in the body (metastatic) or cannot be removed by surgery (unresectable) for genetic mutations for recommendation to a molecularly assigned therapy. Identifying gene mutations may help patients enroll onto target companion trials that target these mutations.
Eligible Conditions
- Colon Cancer
- Rectal Cancer
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 3.5 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3.5 years
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Companion Trial Enrollment
The Proportion of Patients Who Have an Actionable Genomic Profile
Trial Design
1Treatment groups
Experimental Treatment
Group I: Screening (genetic testing)Experimental Treatment1 Intervention
Patients submit blood samples for genetic testing.
Find a Location
Who is running the clinical trial?
Academic and Community Cancer Research UnitedLead Sponsor
53 Previous Clinical Trials
4,802 Total Patients Enrolled
National Cancer Institute (NCI)NIH
13,842 Previous Clinical Trials
41,002,801 Total Patients Enrolled
John H StricklerPrincipal InvestigatorAcademic and Community Cancer Research United
4 Previous Clinical Trials
134 Total Patients Enrolled
Share this study with friends
Copy Link
Messenger